Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared with Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
Stroke 49:1464-1470, Reddy, V.Y.,et al, 2018
See this aricle in Pubmed

Article Abstract
Upfront procedure costs initially make LAAC higher cost than warfarin and the non-vitamin K antagonist oral anticoagulants, but within 10 years, LAAC delivers more quality-adjusted life years and has lower total costs, making LAAC the most cost-effective treatment strategy for secondary prevention of stroke in atrial fibrillation.
 
Related Tags
(click to filter results - removes previous filter)

anticoagulant,treatment
atrial appendage closure
atrial fibrillation
atrial fibrillation,surgical treatment
cerebrovascular accident,prevention of
cerebrovascular accident,secondary prevention
cost effectiveness
coumarin
factor Xa inhibitor
left atrial appendage,percutaneous closure
non-vitamin K antagonist oral anticoagulants
treatment of neurologic disorder
Watchman device

Click Here to return To Results